Savara Inc (SVRA) News Headlines

▮ More

Date

Headline

10/3/2019 6:39:26 AM Healthcare Stocks That Plunged To New Lows (SVRA, ONCY, MTFB…)

10/2/2019 8:05:01 AM Savara Announces FDA Response From Type C Meeting On Molgradex For APAP Development Program

9/24/2019 10:23:04 PM 5 Top Gainers In Healthcare Sector Today (OVID, ZEAL, VCNX…)

6/12/2019 7:01:46 PM Savara Shares Sink 72% After Late-stage Study Fails

6/2/2019 11:39:15 PM Not For The Faint-hearted Though...

12/19/2018 8:08:27 AM Savara Announces Interim Results From OPTIMA, A Phase 2a Clinical Study

9/27/2018 8:12:12 AM Savara Provides Enrollment Update On Molgradex Impala And OPTIMA Clinical Studies; Affirms View For Topline Data

9/18/2018 7:00:36 AM BioTime Implements New Leadership Structure; Appoints Brian Culley As CEO

8/9/2018 4:05:17 PM Savara Q2 Loss Per Share Of $0.38 Vs. $0.90 Last Year

7/26/2018 9:17:37 AM Savara Prices Public Offering Of 4.25 Mln Shares At $11.50 Per Share

7/25/2018 4:28:37 PM Savara Announces Proposed Public Offering Of Common Stock

5/29/2018 8:29:28 PM CODX Explodes, AXON Completes Restructuring, No Time To Frown For EOLS

5/29/2018 8:08:18 AM Savara Update On Case Reports Of Inhaled Granulocyte-Macrophage Colony Stimulating Factor For Treatment Of NTM

3/13/2018 8:04:32 AM Savara Initiates Phase 2a Study Of Molgradex For Treatment Of NTM Lung Infection

3/12/2018 12:30:17 AM SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch

3/11/2018 1:30:33 PM Savara : Aironite Fails To Meet Primary Endpoint In Indie Phase 2 Study

3/11/2018 11:24:05 AM Aironite Fails To Meet Primary Endpoint In Indie Phase 2 Study Conducted By Heart Failure Clinical Research Network

3/11/2018 12:22:03 AM An Ear To The Pharma: 4 Stocks To Watch This Week

3/3/2018 9:19:34 PM An Ear To The Pharma: 7 Stocks To Watch This Week

2/16/2018 8:17:22 AM Savara To Present Top Line Results From Aironite Phase 2 Clinical Trial For Treatment Of HFpEF

Older Articles